Rein Therapeutics Q2 EPS $(0.10) Beats $(0.17) Estimate

Benzinga · 1d ago
Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.17) by 41.18 percent. This is a 64.29 percent increase over losses of $(0.28) per share from the same period last year.